On November 11, Rocket Lab USA, Inc. rose 4.82% in Regular Trading, trading around $66.68, with turnover of $385 million.
The move coincided with continued market digestion of the company’s proposed roughly $8 billion acquisition of Iridium Communications, alongside supportive Wall Street target-price revisions that remained firmly above the current share price.
Recent coverage indicated Morgan Stanley trimmed its target price to $103 from $105 while maintaining an Overweight rating, while the analyst mean target stood at $108.70 and Needham also kept a triple-digit target. Separately, the proposed Iridium deal has drawn attention during FCC merger review after SpaceX raised spectrum-competition concerns while stating it does not oppose the transaction, keeping the acquisition in focus as a strategic catalyst despite Rocket Lab’s recent Q3 profit miss.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments